Evaluation of Nigella sativa oil loaded electrospun polyurethane nanofibrous mat as wound dressing
Source abstract
Abstract
Electrospun nanofibers have a natural wound healing effect due to their similarity to the extracellular matrix (ECM). Nigella sativa oil, which has therapeutic properties, is used for a wide variety of applications in traditional medicine. The aim of this study was to investigate the release characteristic and wound healing performance of Nigella sativa oil (NSO) loaded polyurethane (PU) electrospun nanofibrous mats in wound dressing applications. In addition, the antibacterial activity and cytotoxicity of the electrospun mats were studied. Analyses using a scanning electron microscope (SEM) showed that PU/NSO nanofibrous mat with an average fiber diameter of 416 ± 66 nm were successfully fabricated. NSO was released at a maximum ratio of 30% from the electrospun mat, and the Korsmeyer-Peppas model was identified as best for determining the release mechanism. Significant antibacterial activity was observed against Staphylococcus aureus (90.26%) and Escherichia coli (95.75%). The developed PU/NSO nanofibrous mat increased the cell viability more than 100% in human umbilical vein endothelial cell line (HUVEC) cell line. The NSO loaded PU nanofibrous mat significantly promoted the wound healing process on a rat wound model, and its wound closure reached approximately 85% compared to the control groups on the 9th day (p < 0.01). The results indicated PU/NSO nanofibrous mat is a suitable candidate for a wound dressing.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Medical and Biological Ozone Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department Textile of Engineering, Faculty of Engineering, Bursa Uludag University
Department of Chemistry, Faculty of Arts and Science, Bursa Uludag University
Department of Pharmacology, Faculty of Medicine, Bursa Uludag University
Inovenso Technology Limited, IOSB
References (65)
Show source-provided references
1. 10.1016/j.ijbiomac.2020.03.20710.1016/j.ijbiomac.2020.03.207 ↗
2. 10.1080/00405000.2020.182855310.1080/00405000.2020.1828553 ↗
3. 10.1016/B978-0-323-52727-9.00009-110.1016/B978-0-323-52727-9.00009-1 ↗
4. 10.1002/mabi.20130056110.1002/mabi.201300561 ↗
5. 10.3390/molecules2511269910.3390/molecules25112699 ↗
6. 10.2174/156720181566618072311432610.2174/1567201815666180723114326 ↗
7. 10.1016/j.carbpol.2018.06.07210.1016/j.carbpol.2018.06.072 ↗
8. 10.1016/j.mtchem.2019.03.00810.1016/j.mtchem.2019.03.008 ↗
9. 10.1016/S0266-3538(03)00178-710.1016/S0266-3538(03)00178-7 ↗
10. 10.1016/B978-0-12-801559-9.00010-710.1016/B978-0-12-801559-9.00010-7 ↗
11. 10.1016/S0168-3659(99)00256-410.1016/S0168-3659(99)00256-4 ↗
12. 10.1016/B978-0-12-813663-8.00004-X10.1016/B978-0-12-813663-8.00004-X ↗
13. 10.1016/j.jconrel.2015.10.04910.1016/j.jconrel.2015.10.049 ↗
14. 10.1016/j.biomaterials.2008.01.01110.1016/j.biomaterials.2008.01.011 ↗
15. 10.1142/589410.1142/5894 ↗
16. 10.1016/j.jconrel.2014.04.01810.1016/j.jconrel.2014.04.018 ↗
17. 10.1016/S2221-1691(13)60075-110.1016/S2221-1691(13)60075-1 ↗
18. Forouzanfar F, Bazzaz BSF, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): A review on antimicrobial effects. Iran J Basic Med Sci. 2014;17(12):929–938.
19. 10.1080/10408398.2016.127797110.1080/10408398.2016.1277971 ↗
20. 10.1002/ptr.139010.1002/ptr.1390 ↗
21. 10.1016/j.biocel.2005.10.00910.1016/j.biocel.2005.10.009 ↗
22. 10.5455/jice.2016101802123810.5455/jice.20161018021238 ↗
23. 10.1016/j.jep.2005.04.00210.1016/j.jep.2005.04.002 ↗
24. 10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q ↗
25. 10.1097/BCR.0b013e31827a2be110.1097/BCR.0b013e31827a2be1 ↗
26. 10.1016/j.ijbiomac.2017.07.14510.1016/j.ijbiomac.2017.07.145 ↗
27. 10.1007/s12633-018-9931-z10.1007/s12633-018-9931-z ↗
28. 10.1007/s10924-020-01700-310.1007/s10924-020-01700-3 ↗
29. 10.1080/00405000.2020.183116810.1080/00405000.2020.1831168 ↗
30. 10.1080/00405000.2020.183116810.1080/00405000.2020.1831168 ↗
31. 10.1016/j.matpr.2019.08.22110.1016/j.matpr.2019.08.221 ↗
32. 10.1002/app.4952810.1002/app.49528 ↗
33. 10.1007/s10856-010-4006-810.1007/s10856-010-4006-8 ↗
34. 10.1002/jbm.b.1005810.1002/jbm.b.10058 ↗
35. 10.1038/s41598-020-59931-210.1038/s41598-020-59931-2 ↗
36. 10.1007/s12221-011-0207-010.1007/s12221-011-0207-0 ↗
37. 10.1166/jnn.2010.282910.1166/jnn.2010.2829 ↗
38. 10.1080/10601325.2010.50800110.1080/10601325.2010.508001 ↗
39. 10.1016/j.polymertesting.2017.05.00810.1016/j.polymertesting.2017.05.008 ↗
40. 10.1016/j.colsurfa.2012.09.02910.1016/j.colsurfa.2012.09.029 ↗
41. 10.2147/IJN.S5411310.2147/IJN.S54113 ↗
42. 10.1080/1023666X.2020.176678610.1080/1023666X.2020.1766786 ↗
43. 10.1016/j.ijpharm.2019.11859010.1016/j.ijpharm.2019.118590 ↗
44. 10.1177/152808371880878710.1177/1528083718808787 ↗
45. 10.17482/uumfd.56035810.17482/uumfd.560358 ↗
46. 10.1016/0378-5173(90)90391-G10.1016/0378-5173(90)90391-G ↗
47. 10.1002/jps.260052121010.1002/jps.2600521210 ↗
48. 10.1016/0168-3659(87)90034-410.1016/0168-3659(87)90034-4 ↗
49. 10.1016/j.eurpolymj.2019.05.02010.1016/j.eurpolymj.2019.05.020 ↗
50. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
51. 10.1016/j.ceramint.2019.08.29010.1016/j.ceramint.2019.08.290 ↗
52. Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–223.
53. 10.4103/0973-1296.19145910.4103/0973-1296.191459 ↗
54. 10.1078/0944-7113-0008410.1078/0944-7113-00084 ↗
55. Singh S, Das SS, Singh G, et al. Composition, in vitro antioxidant and antimicrobial activities of essential oil and oleoresins obtained from black cumin seeds (Nigella sativa L.). BioMed Res Int. 2014; 2014:1–10.10.1155/2014/918209 ↗
56. 10.1016/j.fct.2007.09.10610.1016/j.fct.2007.09.106 ↗
57. 10.1016/j.sajb.2009.10.00910.1016/j.sajb.2009.10.009 ↗
58. 10.1016/j.indcrop.2012.07.06910.1016/j.indcrop.2012.07.069 ↗
59. 10.3390/pharmaceutics1111057010.3390/pharmaceutics11110570 ↗
60. 10.1039/C4TB01974A10.1039/C4TB01974A ↗
61. 10.1128/CMR.12.1.14710.1128/CMR.12.1.147 ↗
62. 10.1097/01.prs.0000225430.42531.c210.1097/01.prs.0000225430.42531.c2 ↗
63. 10.2217/nnm.15.21110.2217/nnm.15.211 ↗
64. 10.1016/S0378-8741(02)00356-210.1016/S0378-8741(02)00356-2 ↗
65. 10.3390/ijerph1711416010.3390/ijerph17114160 ↗